A STUDY OF MEHD7945A IN COMBINATION WITH CISPLATIN AND 5-FLUOROURACIL (5-FU) OR PACLITAXEL AND CARBOPLATIN IN PARTICIPANTS WITH RECURRENT/METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (R/M SCCHN):